Antibacterial Activity of Solanum torvum Leaf Extract and Its Synergistic Effect with Oxacillin against Methicillin-Resistant Staphyloccoci Isolated from Dogs
- PMID: 35326765
- PMCID: PMC8944679
- DOI: 10.3390/antibiotics11030302
Antibacterial Activity of Solanum torvum Leaf Extract and Its Synergistic Effect with Oxacillin against Methicillin-Resistant Staphyloccoci Isolated from Dogs
Abstract
Methicillin-resistant staphylococci (MRS) have been considered a veterinary and public health threat that needs to be addressed, as they are known to cause serious infections, with limited therapeutic options. Thus, in this study, we aimed to examine the potential antibacterial activity of the leaf extract of Solanum torvum against MRS isolated from clinically healthy dogs. In total, seven mecA-positive Staphylococcus isolates tested in this study were identified using 16S rRNA gene sequencing, and all of them were classified as multidrug-resistant using disk diffusion tests. According to gas chromatography-mass spectrometry analysis, the main phytochemical components found in the leaf extract were hexadecanoic acid and its ethyl ester and 9,12,15-octadecatrienoic acid, ethyl ester, (Z,Z,Z). The minimum inhibitory concentration (MIC) breakpoints for the leaf extract against all tested isolates ranged from 2 to 16 mg/mL, while the MIC breakpoints for oxacillin were from 2 to 512 mg/L. Although varying effects were found, the positive effects of the leaf extract were most evident in combination with oxacillin. These results suggested that S. torvum leaf extract may complement classical antibiotics and may potentially drive the development of an effective therapeutic option for MRS.
Keywords: antimicrobials; dog; resistance; staphylococci.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group.J Clin Microbiol. 2016 Mar;54(3):535-42. doi: 10.1128/JCM.02864-15. Epub 2015 Nov 25. J Clin Microbiol. 2016. PMID: 26607988 Free PMC article.
-
Presence of mecA-positive multidrug-resistant Staphylococcus epidermidis in bovine milk samples in Brazil.J Dairy Sci. 2016 Feb;99(2):1374-1382. doi: 10.3168/jds.2015-9931. Epub 2015 Dec 17. J Dairy Sci. 2016. PMID: 26709182
-
Evaluation of susceptibility test breakpoints used to predict mecA-mediated resistance in Staphylococcus pseudintermedius isolated from dogs.J Vet Diagn Invest. 2009 Jan;21(1):53-8. doi: 10.1177/104063870902100108. J Vet Diagn Invest. 2009. PMID: 19139501
-
[Detection of mecA in strains with oxacillin and cefoxitin disk tests for detection of methicillin-resistant Staphylococcus].Korean J Lab Med. 2007 Aug;27(4):276-80. doi: 10.3343/kjlm.2007.27.4.276. Korean J Lab Med. 2007. PMID: 18094588 Korean.
-
In Vitro Antimicrobial Activity of Piper betle Leaf Extract and Some Topical Agents against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Strains from Canine Pyoderma.Animals (Basel). 2022 Nov 18;12(22):3203. doi: 10.3390/ani12223203. Animals (Basel). 2022. PMID: 36428430 Free PMC article.
Cited by
-
Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella enterica subsp. Enterica serovar typhimurium.Microorganisms. 2022 Nov 29;10(12):2360. doi: 10.3390/microorganisms10122360. Microorganisms. 2022. PMID: 36557613 Free PMC article.
-
Exploring Medicinal Plants for Antimicrobial Activity and Synergistic Effects With Doxycycline Against Bacterial Species.ScientificWorldJournal. 2024 Oct 3;2024:6238852. doi: 10.1155/2024/6238852. eCollection 2024. ScientificWorldJournal. 2024. PMID: 39416681 Free PMC article.
-
Synergistic antibacterial action of the iron complex and ampicillin against Staphylococcus aureus.BMC Microbiol. 2023 Oct 6;23(1):288. doi: 10.1186/s12866-023-03034-1. BMC Microbiol. 2023. PMID: 37803300 Free PMC article.
-
In Vitro Synergistic Inhibitory Effects of Plant Extract Combinations on Bacterial Growth of Methicillin-Resistant Staphylococcus aureus.Pharmaceuticals (Basel). 2023 Oct 20;16(10):1491. doi: 10.3390/ph16101491. Pharmaceuticals (Basel). 2023. PMID: 37895962 Free PMC article.
References
-
- Feßler A.T., Schuenemann R., Kadlec K., Hensel V., Brombach J., Murugaiyan J., Oechtering G., Burgener I.A., Schwarz S. Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) among employees and in the environment of a small animal hospital. Vet. Microbiol. 2018;221:153–158. doi: 10.1016/j.vetmic.2018.06.001. - DOI - PubMed
-
- Ortiz-Díez G., López R., Sánchez-Díaz A.M., Turrientes M.C., Baquero M.R., Luque R., Maroto A., Fernández C., Ayllón T. Epidemiology of the colonization and acquisition of methicillin-resistant staphylococci and vancomycin-resistant enterococci in dogs hospitalized in a clinic veterinary hospital in Spain. Comp. Immunol. Microbiol. Infect. Dis. 2020;72:101501. doi: 10.1016/j.cimid.2020.101501. - DOI - PubMed
-
- Loncaric I., Tichy A., Handler S., Szostak M.P., Tickert M., Diab-Elschahawi M., Spergser J., Künzel F. Prevalence of methicillin-resistant Staphylococcus sp. (MRS) in different companion animals and determination of risk factors for colonization with MRS. Antibiotics. 2019;8:36. doi: 10.3390/antibiotics8020036. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources